Skip to content

Clinical study on the prognosis of ECMO

Clinical study on the prognosis of ECMO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058172
Enrollment
Unknown
Registered
2022-03-31
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECMO

Interventions

case series:Nil

Sponsors

The People’s Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: All patients receiving ECMO treatment.

Exclusion criteria

Exclusion criteria: Patients who do not agree to enter the study.

Design outcomes

Primary

MeasureTime frame
Hospital mortality;28 days to 5 years survival rate;

Secondary

MeasureTime frame
ECMO-related complications;Hospital costs;Length of hospital stay;Offline success rate;

Countries

China

Contacts

Public ContactChen Wan

The People's Hospital of Guangxi Zhuang Autonomous Region

wan117@sina.com+86 19968142101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026